- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Indian-origin physician pleads guilty to healthcare fraud
New York: An Indian-origin woman has pleaded guilty to charges of unlawfully distributing controlled substances and health care fraud, US Attorney Scott Brady said.Madhu Aggarwal, 68, of Pennsylvania, pleaded guilty to the charges before United States District Judge Arthur Schwab.Aggarwal, a physician who practised at a clinic in Pennsylvania, and others conspired together to create...
New York: An Indian-origin woman has pleaded guilty to charges of unlawfully distributing controlled substances and health care fraud, US Attorney Scott Brady said.
Madhu Aggarwal, 68, of Pennsylvania, pleaded guilty to the charges before United States District Judge Arthur Schwab.
Aggarwal, a physician who practised at a clinic in Pennsylvania, and others conspired together to create and submit unlawful prescriptions for controlled substances such as buprenorphine and then unlawfully dispensed those substances to other persons.
Schwab scheduled the sentencing for November when she will face a sentence of 10 years in prison and a fine of USD 500,000 for the controlled substances offences.
Aggarwal faces an additional maximum imprisonment of 10 years and a fine of USD 250,000 for the health care fraud charge.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.